AUCZANDER XR

Serial Number 97683803
733

Registration Progress

Application Filed
Nov 18, 2022
Under Examination
Dec 5, 2023
Approved for Publication
Oct 10, 2023
Published for Opposition
Oct 10, 2023
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jun 05, 2026 136 days

Trademark Image

AUCZANDER XR

Basic Information

Serial Number
97683803
Filing Date
November 18, 2022
Published for Opposition
October 10, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Dec 4, 2025
Application
Pending
Classes
005

Rights Holder

Aucta Pharmaceuticals, Inc.

03
Address
71 Suttons Lane
Piscataway, NJ 08854

Ownership History

Aucta Pharmaceuticals, Inc.

Original Applicant
03
Piscataway, NJ

Aucta Pharmaceuticals, Inc.

Owner at Publication
03
Piscataway, NJ

Legal Representation

Attorney
Michael J. Leonard

USPTO Deadlines

Next Deadline
136 days remaining
NOA E-Mailed - SOU Required
Due Date
June 05, 2026
Extension Available
Until December 05, 2026

Application History

28 events
Date Code Type Description Documents
Dec 4, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 4, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Dec 4, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Dec 4, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 5, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 5, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 5, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 5, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 5, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 4, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 4, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 4, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 4, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 5, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 10, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 10, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 20, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 1, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 1, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 1, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 1, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Sep 1, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 31, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 22, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 22, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations or substances for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"XR"